>> View All Results for ""
Enter multiple symbols separated by commas
London quotes now available
Considering the FDA ban on drugs manufactured at the company¿s Toansa unit, Nitin Agarwal, Analyst at IDFC Securities, says there are too many risks to buy into Ranbaxy shares. The Indian firm is due to release earnings on Wednesday.